https://vital.seals.ac.za/vital/access/manager/Index ${session.getAttribute("locale")} 5 https://vital.seals.ac.za/vital/access/manager/Repository/vital:35362 125 μM) was observed. Similarly, these compounds exhibited moderate activity against the human protozoal pathogen Trichomonas vaginalis with no observed effect on common microbiome bacterial species. The cross-species inhibitory activity presents the possibility of these compounds serving as broad-spectrum antibiotics for these prevalent three human pathogens.]]> Tue 07 May 2024 12:34:59 SAST ]]> https://vital.seals.ac.za/vital/access/manager/Repository/vital:35407 50 % was often observed. Except for compound 9o, none of the final compounds exhibited cytotoxic effects against HeLa cells at 20 μM.]]> Tue 07 May 2024 12:31:51 SAST ]]> https://vital.seals.ac.za/vital/access/manager/Repository/vital:35410 Tue 07 May 2024 12:28:22 SAST ]]> https://vital.seals.ac.za/vital/access/manager/Repository/vital:41242 Tue 07 May 2024 11:44:11 SAST ]]> https://vital.seals.ac.za/vital/access/manager/Repository/vital:38827 Tue 07 May 2024 11:21:22 SAST ]]> https://vital.seals.ac.za/vital/access/manager/Repository/vital:41240 Tue 07 May 2024 11:20:07 SAST ]]> https://vital.seals.ac.za/vital/access/manager/Repository/vital:35647 Tue 07 May 2024 10:34:28 SAST ]]>